Report Tools

Abbott Laboratories - SWOT, Strategy and Corporate Finance Report

Published: July 2013 · Publisher: MarketLine
Abbott Laboratories - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages81
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6431
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
Abbott Laboratories - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Abbott Laboratories required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Abbott Laboratories in the form of a SWOT analysis
- An in-depth view of the business model of Abbott Laboratories including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Abbott Laboratories
- Intelligence on Abbott Laboratoriesnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Abbott Laboratories, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Abbott Laboratories (Abbott or 'the company') is a diversified healthcare company with a portfolio diagnostic products, medical devices, nutritionals and branded generic pharmaceuticals. The company markets its products in several countries, with major operations in the US, the Netherlands, Germany, Japan, Italy, France, Canada, the UK and Spain. It is headquartered in Abbott Park, Illinois, and employs about 70,000 people. In January 2013, Abbott completed the separation of its research-based pharmaceuticals business through the distribution of the issued and outstanding common stock of AbbVie Inc. (AbbVie) to Abbott's shareholders. AbbVie was formed to hold Abbott's research-based pharmaceuticals business and, as a result of the distribution, is now an independent public company trading under the symbol ‘ABBV’ on the New York Stock Exchange. Abbott recorded revenues of $39,873.9 million during the financial year ended March 2012 (FY2012), an increase of 2.6% over FY2011. The operating profit of the company was $8,084.5 million in FY2012, an increase of 40.6% over FY2011. The net profit was $5,962.9 million in FY2012, an increase of 26.1% over FY2011.

Reasons to Purchase:

- Gain understanding of Abbott Laboratories and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Abbott Laboratories as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Abbott Laboratories’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Abbott Laboratories: Company Overview
Abbott Laboratories: Overview and Key Facts
Abbott Laboratories: Overview
Abbott Laboratories: Key Facts
Abbott Laboratories: Key Employees
Abbott Laboratories: Key Employee Biographies
Abbott Laboratories: Major Products and Services
Abbott Laboratories: Company History
Abbott Laboratories: Management Statement
Abbott Laboratories: Locations and Subsidiaries
Abbott Laboratories: Key Competitors
Abbott Laboratories: Company Analysis
Abbott Laboratories: Business Description
Abbott Laboratories: SWOT Analysis
Abbott Laboratories: SWOT Overview
Abbott Laboratories: Strengths
Abbott Laboratories: Weaknesses
Abbott Laboratories: Opportunities
Abbott Laboratories: Threats
Abbott Laboratories: Financial Analysis
Abbott Laboratories: Financial Overview
Abbott Laboratories: Five Year Company Financials
Abbott Laboratories: Key Income Statement Data
Abbott Laboratories: Key Balance Sheet Data
Abbott Laboratories: Key Cash Flow Data
Abbott Laboratories: Key Market Data
Abbott Laboratories: Valuation Ratios
Abbott Laboratories: Profitability Ratios
Abbott Laboratories: Management Efficiency Ratios
Abbott Laboratories: Financial Strength Ratios
Abbott Laboratories: Operational Efficiency Ratios
Abbott Laboratories: Others
Abbott Laboratories: Corporate Financial Deals Activity
Abbott Laboratories: Financial Deals Overview
Abbott Laboratories: Targets and Partners
Abbott Laboratories: Top Deals 2009 - 2013YTD*
Abbott Laboratories: Advisors
Abbott Laboratories: Top Legal Advisors
Abbott Laboratories: Top Financial Advisors
Abbott Laboratories: Mergers and Acquisitions
Abbott Laboratories: Corporate Venturing
Abbott Laboratories: Capital Raising
Abbott Laboratories: Partnership
Abbott Laboratories: Divestments
Abbott Laboratories: Recent Developments
Abbott Laboratories: News and Events Summary
Abbott Laboratories: Financial Deals
Abbott Laboratories: Regulatory and Legal Events
Abbott Laboratories: Research & Development
Abbott Laboratories: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: Abbott Laboratories: Key Facts
Table 2: Abbott Laboratories: Key Employees
Table 4: Abbott Laboratories: Key Competitors
Table 5: Abbott Laboratories: Key Income Statement Data
Table 6: Abbott Laboratories: Key Balance Sheet Data
Table 7: Abbott Laboratories: Key Cash Flow Data
Table 8: Abbott Laboratories: Key Market Data
Table 9: Abbott Laboratories: Key Growth Ratios
Table 10: Abbott Laboratories: Valuation Ratios
Table 11: Abbott Laboratories: Profitability Ratios
Table 12: Abbott Laboratories: Management Efficiency Ratios
Table 13: Abbott Laboratories: Financial Strength Ratios
Table 14: Abbott Laboratories: Operational Efficiency Ratios
Table 15: Abbott Laboratories: Others
Table 16: Abbott Laboratories: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Abbott Laboratories: M&A Activity by Geography (TTM*)
Table 18: Abbott Laboratories: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Abbott Laboratories: M&A Average Deal Size - Value (US$m)
Table 20: Abbott Laboratories: Targets and Partners
Table 21: Abbott Laboratories: Top Deals 2009 - 2013YTD*
Table 22: Abbott Laboratories: Legal Advisor Ranking by Value (US$m)
Table 23: Abbott Laboratories: Financial Advisor Ranking by Value (US$m)
Table 24: Abbott Laboratories: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Abbott Laboratories: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Abbott Laboratories: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Abbott Laboratories: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Abbott Laboratories: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 29: Abbott Laboratories: Capital Raising by Deal Type (2009 - YTD*2013)
Table 30: Abbott Laboratories: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 31: Abbott Laboratories: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 32: Abbott Laboratories: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 33: Abbott Laboratories: Divestments by Geography (2009 - YTD*2013)
Table 34: Abbott Laboratories: News and Events Summary
Table 35: Abbott Laboratories: Financial Deals
Table 36: Abbott Laboratories: Regulatory and Legal Events
Table 37: Abbott Laboratories: Research & Development
Table 38: Abbott Laboratories: Strategy and Operations

List of Figures

Figure 1: Abbott Laboratories: Revenue to Net Income (2008-2012)
Figure 2: Abbott Laboratories: Revenue/Employee to Net Income/Employee (2008-2012)
Figure 3: Abbott Laboratories: Current Assets to Current Liabilities (2008-2012)
Figure 4: Abbott Laboratories: Assets, Liabilities to Total Equity (2008-2012)
Figure 5: Abbott Laboratories: Free Cash Flow to Cash from Operating Activities (2008-2012)
Figure 6: Abbott Laboratories: Net Change in Cash (2008-2012)
Figure 7: Abbott Laboratories: Market Capitalization to Year-end Share Price (2008-2012)
Figure 8: Abbott Laboratories: Enterprise Value (2008-2012)
Figure 9: Abbott Laboratories: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Abbott Laboratories: M&A Activity by Geography (TTM*)
Figure 11: Abbott Laboratories: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Abbott Laboratories: M&A Average Deal Size - Value (US$m)
Figure 13: Abbott Laboratories: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Abbott Laboratories: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Abbott Laboratories: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Abbott Laboratories: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Abbott Laboratories: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 18: Abbott Laboratories: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 19: Abbott Laboratories: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 20: Abbott Laboratories: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 21: Abbott Laboratories: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 22: Abbott Laboratories: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.